Brookings: No Surprises IDR Process May Hike Costs, Premiums

By Amy Lotven / April 11, 2024 at 12:22 PM
The No Surprises Act’s independent dispute resolution (IDR) mechanism that Congress’ scorekeeper had believed would reduce costs over the first decade may end up raising in-network prices and premiums, according to a recent Brookings Institution report analyzing the first tranche of IDR outcome data released by CMS in February, which suggest lawmakers’ goal of ending surprise billing without increasing rates is in jeopardy. It’s a pretty shocking outcome considering congressional committee leaders, the Congressional Budget Office and other experts believed...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.